2.27
+0(+0.00%)
Currency In USD
| Previous Close | 2.27 |
| Open | 2.27 |
| Day High | 2.27 |
| Day Low | 2.27 |
| 52-Week High | 7.25 |
| 52-Week Low | 1.85 |
| Volume | 4.06M |
| Average Volume | 997,031 |
| Market Cap | 229.17M |
| PE | -0.84 |
| EPS | -2.69 |
| Moving Average 50 Days | 2.4 |
| Moving Average 200 Days | 3.55 |
| Change | 0 |
If you invested $1000 in Acelyrin, Inc. (SLRN) since IPO date, it would be worth $126.11 as of July 12, 2025 at a share price of $2.27. Whereas If you bought $1000 worth of Acelyrin, Inc. (SLRN) shares 1 year ago, it would be worth $398.25 as of July 12, 2025 at a share price of $2.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
GlobeNewswire Inc.
May 13, 2025 5:00 PM GMT
LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that at the Company
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
GlobeNewswire Inc.
May 06, 2025 8:30 PM GMT
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction TodayACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharm
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis
GlobeNewswire Inc.
May 01, 2025 5:30 PM GMT
Special Meeting of stockholders to vote on the transaction scheduled for May 13, 2025 Reminds stockholders to vote today FOR the proposed merger LOS ANGELES, May 01, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biop
Data not available